Artivion Inc (AORT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $931.88M
Last updated: Nov 17, 2026 at 4:15 PM ET
Artivion Inc (AORT) Statistics
Artivion (AORT) has a market cap of $931.88M and an enterprise value of $1.25B. Its trailing P/E of 39.7x is below its 10-year median of 86.3x. Its share count is up 3.14% from a year earlier.
Total Valuation
Enterprise value is 34.12% above the market cap, as debt exceeds cash.
| Market Cap | $931.88M |
|---|---|
| Enterprise Value | $1.25B |
| Latest price (Nov 17, 2026) | $18.27 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.8x and 2.0x. Its year-end P/E ranged from 39.9x to 242.4x from 2016 to 2025.
| P/E Ratio | 39.7x |
|---|---|
| P/S Ratio | 1.8x |
| Forward P/S | 1.9x |
| P/B Ratio | 2.0x |
| P/OCF Ratio | 62.6x |
| PEG Ratio | 0.6 |
Enterprise Valuation
Counting debt and cash, the company is valued at 27.6x EBITDA.
| EV / Sales | 2.6x |
|---|---|
| EV / EBITDA | 27.6x |
| EV / EBIT | 71.0x |
Price Statistics
The stock is down 60.02% over 52 weeks and trades 19.20% below its 50-day average.
| Beta (1Y) | 0.37 |
|---|---|
| 52-Week Change | -60.02% |
| 1-Month Change | -18.00% |
| 3-Month Change | -36.61% |
| 6-Month Change | -19.62% |
| 5-Year Change | +9.40% |
| 10-Year Change | +32.82% |
| Total Return (1Y) | -60.02% |
| Total Return (3Y CAGR) | +10.10% |
| Total Return (5Y CAGR) | -1.01% |
| Return vs SPY (1Y) | -70.81% |
| Max Drawdown (1Y) | -61.28% |
| Max Drawdown (3Y) | -61.64% |
| Sharpe Ratio (1Y) | -1.57 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $22.61 |
| 200-Day Average | $28.12 |
| 52-Week Range | $18.11 to $48.25 |
| RSI (14 Days) | 32.4 |
| Average Volume (20 Days) | 810.54K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.42x current liabilities, and total debt is 0.82x shareholder equity.
| Current Ratio | 4.42x |
|---|---|
| Quick Ratio | 3.02x |
| Debt / Equity | 0.82x |
| Debt / EBITDA | 8.37x |
| Interest Coverage | 0.60x |
Returns and Efficiency
Return on invested capital is 2.17% over the last 12 months, against a 5-year average of 2.08%.
| Return on Equity (ROE) | -3.94% |
|---|---|
| Return on Assets (ROA) | -1.69% |
| Return on Invested Capital (ROIC) | 2.17% |
| Return on Capital Employed (ROCE) | 1.82% |
| ROE (5Y Average) | -5.05% |
| ROA (5Y Average) | -1.77% |
| ROIC (5Y Average) | 2.08% |
| Asset Turnover | 0.51x |
| Inventory Turnover | 1.68x |
| Receivables Turnover | 4.44x |
| Cash Conversion Cycle | 260 days |
Scores
AORT has an Altman Z-Score of 1.62, in the distress zone below 1.81, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.62 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $481.88M over the last 12 months is up 14.01% from the 12 months before.
| Revenue | $481.88M |
|---|---|
| Revenue Growth (YoY) | +14.01% |
| Gross Profit | $305.08M |
| Operating Income | $11.05M |
| Pretax Income | -$10.74M |
| Net Income | -$17.59M |
| EBITDA | $43.79M |
| EBIT | $17.60M |
| Reported EPS (TTM) | $0.46 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 42.92% of the $1.04B in total assets.
| Cash and Equivalents | $48.40M |
|---|---|
| Total Debt | $366.36M |
| Net Debt | $317.96M |
| Net Debt Per Share | $6.53 |
| Working Capital | $262.16M |
| Shareholder Equity | $446.40M |
| Book Value Per Share | $9.16 |
| Tangible Book Value | -$120.47M |
| Total Assets | $1.04B |
| Total Liabilities | $595.69M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $59.27M of capital spending, operating cash flow left -$44.38M of free cash flow.
| Operating Cash Flow | $14.89M |
|---|---|
| Capital Expenditures | $59.27M |
| Free Cash Flow | -$44.38M |
| FCF Per Share | -$0.91 |
| Depreciation and Amortization | $26.19M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 2.29%, against a 5-year average of 4.79%.
| Gross Margin | 63.31% |
|---|---|
| Operating Margin | 2.29% |
| Pretax Margin | -2.23% |
| Net Margin | -3.65% |
| EBITDA Margin | 9.09% |
| EBIT Margin | 3.65% |
| FCF Margin | -9.21% |
| Gross Margin (5Y Average) | 64.76% |
| Operating Margin (5Y Average) | 4.79% |
| Net Margin (5Y Average) | -4.19% |
Growth
Revenue grew 12.04% a year over 3 years, and EPS 132.70% a year.
| Revenue Growth (3Y CAGR) | +12.04% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.75% |
| EPS Growth (3Y CAGR) | +132.70% |
| EPS Growth (5Y CAGR) | +22.33% |
| FCF Growth (5Y CAGR) | -30.14% |
| Operating Income Growth (3Y CAGR) | +75.89% |
| Book Value Per Share Growth (2Y CAGR) | +14.53% |
Dividends and Yields
AORT does not pay a dividend. Its free cash flow yield is -4.99%.
| Earnings Yield | 2.52% |
|---|---|
| FCF Yield | -4.99% |
| Buyback Yield | -0.85% |
| Shareholder Yield | -0.85% |
Stock Splits
The last split was a 3-for-2 forward split on Dec 28, 2000.
| Last Split Date | Dec 28, 2000 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 6 similar companies, AORT has the 2nd highest P/E.
P/E RatioPeer median 13.1x
P/S RatioPeer median 1.9x
ROICPeer median -11.35%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.95%
| P/E Ratio | 39.7x vs 13.1x median |
|---|---|
| P/S Ratio | 1.8x vs 1.9x median |
| ROIC | 2.17% vs -11.35% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +14.01% vs +11.95% median |
Analyst Forecast
Consensus estimates put revenue growth at 10.05% and EPS growth at -9.15% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +10.05% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -9.15% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AORT
What is AORT's market cap?
Artivion has a market cap of $931.88M. Its enterprise value, which adds debt and subtracts cash, is $1.25B.
What is AORT's P/E ratio?
Artivion has a trailing P/E ratio of 39.7x.
How many shares of AORT are outstanding?
Artivion has 48.72M shares outstanding. The count is up 3.14% from a year earlier.
Does AORT pay a dividend?
No. Artivion does not pay a dividend.
How much debt does AORT have?
Artivion has $366.36M of total debt and $48.40M of cash and equivalents, a net debt position of $317.96M.
AORT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts